The Efficacy of Intervention Time on Probing Results
DOI:
https://doi.org/10.56056/Keywords:
Congenital nasolacrimal duct obstruction, Epiphora, ProbingAbstract
Background and objectives: Pediatric eye probing is a common treatment for congenital nasolacrimal duct obstruction which affect many infants who might be asymptomatic, careful monitoring should be done. The aim of this study was to determine which pediatric age group benefits most from eye probing in Duhok, Kurdistan region. This study provides insights into the demographics and outcomes of pediatric eye probing, guiding individualized treatment.
Methods: This retrospective cross-sectional study reviewed records of 192 children, aged 1 to 30 months, diagnosed with congenital nasolacrimal duct obstruction at Duhok Eye Hospital between January 1, 2023, and September 1, 2023. Data collected included age, gender, operated eye, and residency. The study observed the outcomes of eye probing.
Results: Majority of children who underwent probing were aged 7-12 months (34.9%), with an even distribution across age groups. Male accounted for 49.5% of cases. Most patients were from Duhok city (66.7%). Surgery was performed on the right eye in 26.0% of cases, the left eye in 33.3%, and both eyes in 40.6%. Procedure was successful in 91.1% of patients, with 90.6% requiring only one operation. The study shows no statistical benefit for the second time operation regarding age and gender, p value = 0.17, and 0.38, respectively.
Conclusion: Eye probing is highly effective for children aged 7-12 months. The observed gender differences in outcomes warrants further research.
Downloads
References
1. Farat JG, Schellini SA, Dib RE, Santos FG, Meneghim RL, Jorge EC. Probing for congenital nasolacrimal duct obstruction: a systematic review and meta-analysis of randomized clinical trials. Arq Bras Oftalmol. 2021 Jan-Feb;84(1):91-98. doi: 10.5935/0004-2749.20210005/
2. Lyons CJ, Lambert SR,. Taylor and Hoyt's Pediatric Ophthalmology and Strabismus. 6th Edition, Elsevier Health Sciences; 2022 May 17.
3. Nguyen AX, Ratan S, Biyani A, Trinh XV, Saleh S, Sun Y, et al. Gender of award recipients in major ophthalmology societies. Am J Ophthalmol. 2021 Nov: 231:120-133. doi: 10.1016/j.ajo.2021.05.021. Epub 2021 Jun 6.
4. Friedman NJ, Kaiser PK, Trattler WB, editors. Review of Ophthalmology-E-Book. 4th Edition. Elsevier Health Sciences; 2022 Apr 30.
5. Oke I, VanderVeen D. Machine Learning Applications in Pediatric Ophthalmology. Semin Ophthalmol. 2021;36(4):210-217. doi:10.1080/08820538.2021.1890151/
6. Wei D, Pu N, Li SY, Wang YG, Tao Y. Application of iontophoresis in ophthalmic practice: an innovative strategy to deliver drugs into the eye. Drug Deliv. 2023; 30(1): 2165736.
7. Lekskul A, Preechaharn P, Jongkhajornpong P, Wuthisiri W. Age-Specific Outcomes of Conservative Approach and Probing for Congenital Nasolacrimal Duct Obstruction. Clin Ophthalmol. 2022; 16:1821-1828. doi:10.2147/OPTH.S362680/
8. Anhalt J, Liu GT, Weiss SJ, Wajda BN, Schnall BM. Rate of spontaneous resolution of congenital nasolacrimal duct obstruction prior to scheduled probing in children older than 1 year. J Pediatr Ophthalmol Strabismus. 2019 Apr 29:56: e31-e33. doi: 10.3928/01913913-20190326-01/
9. Kupzyk S, Zawoyski AM, Cox J. Treatment of noncompliance with eye examination procedures in pediatric primary care. Behav. Anal. Res. Pract. 2021 Feb;21(1):90.
10. Oke I, Elze T, Miller JW, Lorch AC, Hunter DG, Elliott AT, et al. Factors Associated with Nasolacrimal Duct Probing Failure Among Children in the Intelligent Research in Sight Registry. JAMA ophthalmology. 2023 Apr 1;141(4):342-8.
11. Gul S, Dabir S, Jatoi S, Narsani A, Alam M. Efficacy of probing in the treatment of congenital nasolacrimal duct obstruction in three age groups. Int. J. Ophthalmol. 2009;2(1):70-73.
12. Qamar RM, Latif E, Tahir MY, Moin M. Outcome of Delayed Lacrimal Probing in Congenital Obstruction of Nasolacrimal Duct. Pak J Ophthalmol 2011; 27 (4): 175-179.
13. Han X, Bian Y, Yu B. Outcomes Associated with Indwelling Momentary Probe for Congenital Nasolacrimal Duct Obstruction Treatment. J Coll Physicians Surg Pak. 2022 Dec;32(12):1581-1585. doi: 10.29271/jcpsp.2022.12.1581/
14. Morrison DG, Binenbaum G, Chang MY, Heidary G, Trivedi RH, Galvin JA, et al. Office-or facility-based probing for congenital nasolacrimal duct obstruction: a report by the American Academy of ophthalmology. Ophthalmology. 2021 Jun;128(6):920-927. doi: 10.1016/j.ophtha.2020.10.028. Epub 2020 Dec 24.
15. ?wierczy?ska M, Tobiczyk E, Rodak P, Barchanowska D, Filipek E. Success rates of probing for congenital nasolacrimal duct obstruction at various ages. BMC Ophthalmol. 2020;20(1):403. doi:10.1186/s12886-020-01658-9/
16. Rashid W, Shaheen N, Zargar S, Ganie M, Kounsar H. Outcome of Syringing and Probing in Congenital Nasolacrimal Duct Obstruction in Children above Two Years of Age: A Prospective Study. Ann. Int. Med. Dent. Res. 2017;2(5):1-3.
17. Valcheva KP, Murgova SV, Krivoshiiska EK. Success Rate of Probing for Congenital Nasolacrimal Duct Obstruction in Children. Folia Med (Plovdiv). 2019;61(1):97-103. doi:10.2478/folmed-2018-0054/
18. Machado DC, Castro RC, Souza BA, Dias MD, Lima AF, Léda RM, et al. Efficacy of probing for congenital nasolacrimal duct obstruction in a private tertiary hospital: 10-year experience. Rev. Bras. Oftalmol. 2021 Jul 12; 80:133-5.
19. Sharif N, Munir MS, Arshad M, Nazir S, Sadiq MU, Rehman R. Outcome of Probing and Syringing in Congenital Nasolacrimal Duct Obstruction in Children Under Local Anesthesia. Pak Armed Forces Med J 2022, 72 (4), 1415-19. https://doi.org/10.51253/pafmj.v72i4.8160/
20. Perveen S, Sofi A, Rashid S, Khan A. Success Rate of Probing for Congenital Nasolacrimal Duct Obstruction at Various Ages. J Ophthalmic Vis Res. 2014;9(1):60-69.
21. Reynolds M, Lueder G. Outcome of Primary Probing for Simple Membraneous Congenital Nasolacrimal Duct Obstruction in Children Older Than 4 Years. J Pediatr Ophthalmol Strabismus. 2020;57(1):44-47. doi:10.3928/01913913-20191125-01/
22. Medghalchi A, Mohammadi MJ, Moghadam RS, Dalili H. Results of nasolacrimal duct probing in children between 9-48 months. Acta Medica Iranica. 2014:545-51.
23. Bach A, Vanner EA, Warman R. Efficacy of Office-Based Nasolacrimal Duct Probing. J Pediatr Ophthalmol Strabismus. 2019;56(1):50-54. doi:10.3928/01913913-20180925-01/
24. Zhou N, Huo F, Yue Y, Yin C. Specific Fluorescent Probe Based on "Protect-Deprotect" To Visualize the Norepinephrine Signaling Pathway and Drug Intervention Tracers. J Am Chem Soc. 2020;142(41):17751-17755. doi:10.1021/jacs.0c08956/
25. Elazar Y, Ravfogel S, Jacovi A, Goldberg Y. Amnesic Probing: Behavioral Explanation with Amnesic Counterfactuals. 2021. Available from: arXiv:2006.00995/
26. Ulas B, Ozcan A, Ademoglu M. Comparison of success rates of probing surgery in congenital nasolacrimal duct obstruction by age range. Çukurova med. J. 2023; 48 (1): 101 - 108, https://doi.org/10.17826/cumj.1186079/
27. Valcheva KP, Murgova SV, Krivoshiiska EK. Success Rate of Probing for Congenital Nasolacrimal Duct Obstruction in Children. Folia Med (Plovdiv). 2019 Mar 1;61(1):97-103. doi: 10.2478/folmed-2018-0054/
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Araz Abdal Hussein, Nour Mowafaq Masood Alnaqshabandi, Neshtiman Hashim Abdulrahman
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in AMJ (The Scientific Journal of Kurdistan Higher Council of Medical Specialties )is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0)
